Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double‐blind, randomized, placebo‐controlled clinical trial

JP Kaltwasser, P Nash, D Gladman… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an
oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, …

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis

…, FC Breedveld, EM Lemmel, JP Kaltwasser… - …, 2000 - academic.oup.com
Objective. To compare the clinical efficacy and safety of leflunomide and methotrexate for the
treatment of rheumatoid arthritis (RA). Methods. In this multicentre, double‐blind trial, 999 …

[HTML][HTML] Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine

N Frickhofen, JP Kaltwasser… - … England Journal of …, 1991 - Mass Medical Soc
Background and Methods. Immunosuppression is the most effective treatment for patients
with aplastic anemia, except for bone marrow transplantation. The best results are achieved …

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

N Frickhofen, H Heimpel, JP Kaltwasser… - Blood, The Journal …, 2003 - ashpublications.org
Immunosuppression with antithymocyte globulin, (methyl)prednisolone, and cyclosporin A
is considered the treatment of choice for the patient with aplastic anemia without a donor for …

Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis

JP Kaltwasser, E Werner, K Schalk, C Hansen… - Gut, 1998 - gut.bmj.com
Background—Black tea is known to be a potent inhibitor of intestinal absorption of non-haem
iron at least in healthy subjects. Aims—To investigate this effect in patients with genetic …

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.

…, JW Eschbach, P Grützmacher, JP Kaltwasser… - Clinical …, 1997 - europepmc.org
Much progress has been made in recent years in the management of anemia associated
with chronic and renal failure with recombinant human erythropoietin (r-Hu EPO). However, …

Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.

JP Kaltwasser, U Kessler, R Gottschalk… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To investigate whether treatment of anemia of chronic disease (ACD) in
patients with rheumatoid arthritis (RA) with recombinant human erythropoietin (rHu-Epo) in …

Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging

JP Kaltwasser, R Gottschalk… - British journal of …, 1990 - Wiley Online Library
A standard magnetic resonance imaging (MRI) system allowing spin echo times of 10 ms was
used to quantitate liver iron concentration in nine healthy normal subjects and 13 patients …

[HTML][HTML] Erythropoietin and iron

JP Kaltwasser, R Gottschalk - Kidney international, 1999 - Elsevier
Erythropoietin and iron. Serum ferritin concentration is most informative in estimating the
amount of storage iron available for a particular individual. The serum transferrin receptor …

CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis

…, KH Usadel, E Seifried, JP Kaltwasser… - Tissue …, 1998 - Wiley Online Library
The genetic susceptibility to rheumatoid arthritis is conferred by genes in the human
leukocyte antigen (HLA) region on chromosome 6, but additional genes may be involved to …